Advanced Elementary...
Health Care: Drugs
AVANIR Pharmaceuticals (AVNR: NASDAQ)
$4.61 0.00 | -0.11%
06/19/13 - 11:26 AM ET
Company Balance Sheet
| Sep 2012 | Sep 2011 | Sep 2010 | Sep 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 69.78M | 79.54M | 38.77M | 31.49M |
| Receivables | 7.23M | 2.01M | 580.91K | 0.00 |
| Inventories | 415.48K | 252.24K | 652.63K | 114.10K |
| Other Current Assets | 865.34K | 520.49K | 52.87K | 331.72K |
| Total Current Assets | 80.91M | 84.39M | 40.69M | 32.53M |
| Property, Plant & Equipment, Gross | 4.38M | 3.57M | 2.45M | 2.12M |
| Accumulated Depreciation & Depletion | 2.58M | 1.88M | 2.00M | 1.81M |
| Property, Plant & Equipment, Net | 1.81M | 1.70M | 449.71K | 310.68K |
| Intangibles | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Assets | 3.29M | 3.56M | 1.00M | 1.23M |
| Total Non-Current Assets | 5.10M | 5.26M | 1.45M | 1.54M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 86.01M | 89.65M | 42.14M | 34.07M |
| Accounts Payable | 2.93M | 3.26M | 2.11M | 1.21M |
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Liabilities | 20.32M | 14.19M | 7.72M | 5.84M |
| Long Term Debt | 26.70M | 0.00 | 0.00 | 0.00 |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 2.16M | 4.12M | 6.41M | 8.28M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 28.86M | 4.12M | 6.41M | 8.28M |
| Total Liabilities | 49.17M | 18.31M | 14.13M | 14.13M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 36.84M | 71.34M | 28.01M | 19.94M |
| Common Par | 13.64K | 12.54K | 9.60K | 8.31K |
| Additional Paid In Capital | 461.88M | 436.64M | 332.10M | 297.92M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -425.06M | -365.32M | -304.68M | -277.99M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 0.00 | 0.00 | 580.91K | 0.00 |
| Total Capitalization | 63.54M | 71.34M | 28.01M | 19.94M |
| Total Equity | 36.84M | 71.34M | 28.01M | 19.94M |
| Total Liabilities & Stock Equity | 86.01M | 89.65M | 42.14M | 34.07M |
| Total Common Shares Outstanding | 136.44M | 125.44M | 95.97M | 83.08M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 133.36M | 119.41M | 87.61M | 78.84M |
| Diluted Weighted Shares Outstanding | 133.36M | 119.41M | 87.61M | 78.84M |
| Number of Employees | 225 | 188 | 128 | 20 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with AVNR
- Portfolio NameUser Type
- ContributorEarnings Short Squeeze Play...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- Contributor10 Most Shorted Stocks in B...
- Contributor5 Stocks Under-$10 Setting ...
- Contributor5 Biotech Drug-Launch Stock...
- ContributorBreakout Stocks Of The Week...
- UserMy Portfolio
- Contributor6 Heavily Shorted Stocks 04...
Latest AVNR Headlines from TheStreet
- July Options Now Available For Avanir Pharmaceuticals (AVNR) 05.20.13 | 03:05 pm
- Arena Pharmaceuticals And 6 More Stocks To Watch 01.07.13 | 07:01 pm
- 5 Stocks Facing an Earnings Short Squeeze 12.10.12 | 12:12 pm
- 5 Stocks Under $10 Set to Soar Higher 08.30.12 | 12:08 pm
- Avanir Pharmaceuticals' CEO Presents At Canaccord Genuity 32nd Annual Growth Conference (Transcript) 08.14.12 | 02:08 pm
- Avanir Pharmaceuticals' CEO Discusses F3Q12 Results - Earnings Call Transcript 08.08.12 | 09:08 pm
- Avanir Pharmaceuticals CEO Presents At Bank Of America Merrill Lynch Health Care Conference (Transcript) 05.17.12 | 05:05 pm
- Avanir Pharmaceuticals' Presents At Deutsche Bank Securities Annual Health Care Conference (Transcript) 05.09.12 | 11:05 pm
- Avanir Pharmaceuticals' CEO Discusses F2Q2012 Results - Earnings Call Transcript 05.08.12 | 03:05 pm
- Avanir's CEO Presents At Citi 2012 Global Health Care Conference - Transcript 02.29.12 | 01:02 pm
Press Releases for AVNR
- Avanir Pharmaceuticals Announces Appointment Of Corinne Nevinny To Board Of Directors - PR Newswire 03.11.13 | 04:03 pm
- AVANIR PHARMACEUTICALS ANNOUNCES RESEARCH COLLABORATION WITH DEPARTMENT OF VETERANS AFFAIRS FOR SCREENING PSEUDOBULBAR AFFECT (PBA) SYMPTOMS IN VETERANS WITH TRAUMATIC BRAIN INJURY - PR Newswire 03.06.13 | 09:03 am
- AVANIR Pharmaceuticals To Paticipate In Two Conferences In March - PR Newswire 03.01.13 | 09:03 am
- Avanir Pharmaceuticals To Present At RBC Capital Markets' 2013 Global Healthcare Conference - PR Newswire 02.14.13 | 04:02 pm
- Avanir Pharmaceuticals Announces Positive Interim Data From Pharmacokinetic Study With Next Generation Compound AVP-786 - PR Newswire 02.07.13 | 08:02 am
- Avanir Pharmaceuticals Announces Date Of Fiscal 2013 First Quarter Financial Results And Conference Call - PR Newswire 01.30.13 | 08:01 am
- Avanir Pharmaceuticals Announces Date Of Fiscal 2012 Fourth Quarter And Year End Financial Results And Conference Call - PR Newswire 12.03.12 | 08:12 am
- Avanir Pharmaceuticals Pre-Announces Preliminary Fiscal 2012 Fourth Quarter Results And Provides Clinical Study Update - PR Newswire 11.27.12 | 08:11 am
- Avanir Pharmaceuticals To Present At 24th Annual Piper Jaffray Healthcare Conference - PR Newswire 11.21.12 | 08:11 am
- The Michael J. Fox Foundation Awards Grant To Support Avanir Pharmaceuticals' Clinical Study Of AVP-923 For Levodopa Induced Dyskinesia In Parkinson's Disease - PR Newswire 10.23.12 | 08:10 am
Partner Headlines for AVNR
- Avanir to Expedite AVP-786 Development - Analyst Blog - Zacks 06.07.13 | 12:06 am
- Pre-Market Most Active for Jun 5, 2013 : QQQ, BAC, GSK, GM, UBNT, FB, AEG, F, SAN, AVNR, MSFT, ASML - NASDAQ 06.05.13 | 12:06 pm
- Avanir Pharmaceuticals Earnings: Here’s Why Investors Don’t Like These Results - Wall St. Cheat Sheet 05.08.13 | 07:05 am
- Pre-Market Most Active for Apr 26, 2013 : NOK, QQQ, ASML, BAC, MTU, RESI, JCP, BCS, FB, AVNR, ZNGA, SPNC - NASDAQ 04.26.13 | 12:04 pm
- Acorda: A Biotech Company To Consider - Seeking Alpha 04.13.13 | 09:04 am
- After-Hours Earnings Report for December 12, 2012 : AVNR, INTL - NASDAQ 12.12.12 | 07:12 pm
- Neuralstem Swinging For The ALS Fences - Seeking Alpha 10.29.12 | 09:10 am
- Weekly CEO Sells Highlight: Universal Insurance Holdings Inc, Avanir Pharmaceuticals Inc, Bel ... - GuruFocus 06.30.12 | 11:06 am
- Ultimate Stock Watch List for The Supreme Court's Health Care Ruling - Benzinga 06.28.12 | 09:06 am
- Stocks To Watch: Week Of March 19-23 - Seeking Alpha 03.21.12 | 08:03 am
